In 2008, Joanna Narkiewicz et al. used semi-quantitative RT-PCR and Western blotting to measure HtrA1, HtrA2 and HtrA3 mRNA and protein expression levels in ovarian cancers. This evidence concerns the gene HTRA2 and ovarian carcinoma.